Cytodyn Inc (CYDY)

[Blane]

There is so much riding on the Mechanism of action in terms of its potential that makes Leronlimab a potential Big Pharma disruptor. But a cure here and there means a loss in revenue from those that profit from ongoing disease burden. This is why the cure for Hep C was such an unabated thing. There really was no cure or viable treatment for it. Unlike what is happening with Leronlimab.